The Social Network THESN
Zoekresultaten
Alle resultaten weergeven
  • Registreer
    Inloggen Registreren
    Day Mode

Zoeken

Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken

  • FAVORIETEN
  • Nieuws Feed
  • EXPLORE
  • Pagina
  • Groepen
  • Events
  • Blogs
  • Funding
  • Forums
  • Berichten
  • Articles
  • Gebruikers
  • Pagina
  • Groepen
  • Events
  • David Cracc added new article
    2025-05-30 08:02:12 -
    Chronic Induced Urticaria Clinical and Non-Clinical Studies, Key Companies, Treatment Evaluation, Emerging Therapies, Treatment Algorithm, Pipeline Analysis | Celldex Therapeutics, Jasper Therapeutics
      According to DelveInsight's analysis, the chronic induced urticaria (CIndU) pipeline consists of at least four leading companies actively developing four or more therapeutics to treat chronic induced urticaria. Overview of Chronic Induced Urticaria Chronic induced urticaria (CIndU) is a subtype of chronic urticaria that is triggered by specific physical or environmental factors such as...
    0 Reacties 0 aandelen
    Please log in to like, share and comment!
  • David Cracc added new article
    2025-06-03 09:54:40 -
    Chronic Spontaneous Urticaria Clinical and Nonclinical Studies, Key Companies, Treatment Evaluation, Emerging Therapies, Treatment Algorithms, Pipeline Analysis | United BioPharma, Teva Pharmaceuticals Development, Inc., Amgen, Novartis Pharmaceuticals
        Pipeline insights for chronic spontaneous urticaria, DelveInsight According to DelveInsight analysis, the chronic spontaneous urticaria (CSU) pipeline consists of more than 20 leading companies actively developing more than 20 treatments for CSU. Overview of Chronic Spontaneous Urticaria: Urticaria, commonly known as hives, wheals, or nettle rash, is characterized by itchy, red,...
    0 Reacties 0 aandelen
    Please log in to like, share and comment!
  • Kan Kumar added new article
    2025-05-21 10:07:07 -
    Chronic Urticaria Treatment Market 2032: Clinical Trials, Regulatory Status (FDA, EMA, PDMA), Drug Market Dynamics, Prevalence, Pipeline Treatments, Key Statistics, Key Players – DelveInsight
    Key Players in the Chronic Urticaria MarketMajor pharmaceutical companies active in the chronic urticaria field include Sanofi-Aventis, Merck, UCB, Regeneron, Roche, Principia Biopharma, Novartis, AstraZeneca and Kyowa Kirin. Overview of the chronic urticaria treatment market (Albany, USA)- DelveInsight's "Chronic Urticaria – Market Insights, Epidemiology, and Market Forecast –...
    0 Reacties 0 aandelen
    Please log in to like, share and comment!
  • Kan Kumar added new article
    2025-06-23 08:39:17 -
    From Burden to Breakthrough: The Evolving CSU Market
    Chronic spontaneous urticaria poses significant clinical challenges as a complex skin disorder characterized by recurring, intensely itchy wheals persisting beyond six weeks without identifiable precipitating factors. This troublesome condition frequently manifests alongside angioedema, creating substantial tissue swelling that impacts patients' comfort and daily activities. Healthcare...
    0 Reacties 0 aandelen
    Please log in to like, share and comment!
  • Kan Kumar added new article
    2025-06-19 10:51:12 -
    From Genomic Instability to Market Opportunity: The dMMR Story
    Contemporary cancer treatment has witnessed unprecedented advancement through molecular biomarker integration, establishing the Mismatch Repair Deficiency Market as a pivotal component of precision oncology evolution. Mismatch repair deficiency (dMMR) functions as a fundamental cellular biomarker indicating compromised DNA quality control mechanisms that normally prevent genetic errors during...
    0 Reacties 0 aandelen
    Please log in to like, share and comment!
  • Kan Kumar added new article
    2025-07-14 09:40:55 -
    Paroxysmal Nocturnal Hemoglobinuria Market: Current Status and Growth Drivers
    Paroxysmal Nocturnal Hemoglobinuria (PNH) constitutes a rare, acquired blood disorder that jeopardizes patient health through complement-triggered hemolysis, bone marrow malfunction, and thrombotic complications. This medical condition stems from PIGA gene mutations, creating insufficient protective proteins on red blood cell surfaces. The absence of these critical protective components...
    0 Reacties 0 aandelen
    Please log in to like, share and comment!
© 2025 The Social Network THESN Dutch
English French Dutch
About Voorwaarden Privacy Contact Us Bedrijvengids